http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Association between Timed Up and Go Test and Subsequent Functional Dependency
Ji Eun Lee,Hyejin Chun,Young Sang Kim,Hee-Won Jung,Il-Young Jang,Hyun-Min Cha,손기영,Be Long Cho,권인순,윤종률 대한의학회 2020 Journal of Korean medical science Vol.35 No.3
Background: This study aimed to evaluate the association between baseline results of the Timed Up and Go (TUG) test and subsequent functional dependency occurrence. Methods: From the National Health Insurance Service-Senior Cohort database, we identified 39,519 people who participated in the National Screening Program for Transitional Ages at the age of 66 during 2007–2008. Impaired mobility was defined as taking 10 seconds or longer to perform the TUG test. Functional dependency occurrence was defined as the initiation of receiving national Long-Term Care Insurance services—home care or admission to long-term care facilities. Cox proportional hazard regression models were used to assess the hazard ratios (HRs) for dependency occurrence according to baseline TUG test results. Results: The mean follow-up period was 5.7 years. Occurrence rates of dependency were 2.0 and 3.4 cases per 1,000 person-years in the normal and impaired TUG groups, respectively. Impaired mobility was associated with a higher risk of functional dependency occurrence (adjusted HR [aHR], 1.65; 95% confidence interval [CI], 1.40–1.95; P < 0.001). Additionally, in the subgroup analysis for the participants with intact baseline activities of daily living, impaired mobility was associated with a higher risk of dependency occurrence (aHR, 1.65; 95% CI, 1.33–2.04; P < 0.001). Conclusion: The TUG test might be a useful predictive marker of subsequent functional dependency occurrence. Intervention to prevent functional dependency may be helpful for older adults with impairment on the TUG test.
이지은(Ji Eun Lee),신동욱(Dong Wook Shin),조비룡(Be Long Cho) 대한종양외과학회 2014 Korean Journal of Clinical Oncology Vol.10 No.2
As cancer treatments are developed, cancer survivors are increasing very rapidly. It is assumed that there are now more than 1,000,000 cancer survivors in Korea. Cancer survivor was historically defined as someone who had remained disease-free for 5 years, but the definition has been changed to a person who had experienced cancer from diagnosis. This transition reflects the necessity for long-term care planning as life years beyond cancer diagnosis gets longer. Cancer survivors are newly-appeared patient population who need comprehensive care. They are vulnerable to second-primary cancers, have to be educated for healthy behaviors, and have many comorbidities and psychosocial problems. For the comprehensive approach to cancer survivorship, ‘Shared care model’ has been suggested, and it has been applied to some hospitals in Korea. In this model, oncologists and primary-care physicians care cancer survivors together since cancer diagnosis. During active cancer treatment, the oncologist takes main role for care but the primary-care physician maintains the routine health care. And after active cancer treatment, primary-care physician assumes more responsibility for survivorship care. The oncologist and the primary-care physician have regular communication for effective care. Based on this model, the cancer survivorship is expected to be improved.
Yon Su Kim,Be Long Cho,김우식,Sang Hyun Kim,In Hyeon Jung,Won Yong Sin,Dong Hoon Choi,Sang Jae Lee,Chun Soo Lim,Kyung Pyo Kang,Byung Yeon Yu,Wonju Jeung,Chang Gyu Park 대한가정의학회 2019 Korean Journal of Family Medicine Vol.40 No.4
Background: We assessed the frequency and severity of hypoglycemia in type 2 diabetes mellitus patients treated with sulfonylurea monotherapy or sulfonylurea+metformin.Methods: We conducted a retrospective, observational, cross-sectional study in 2011 and 2012 including patients with type 2 diabetes mellitus aged ≥30 years who were treated with ≥6 months of sulfonylurea monotherapy or sulfonylurea+metformin at 20 university-affiliated hospitals in Korea. At enrollment, glycated hemoglobin (HbA1c) was assessed; participants completed self-reported questionnaires describing hypoglycemia incidents over the past 6 months. A review of medical records up to 12 months before enrollment provided data on demographics, disease history, comorbidities, laboratory results, and drug usage. Results: Of 726 enrolled patients, 719 were included (55.6% male); 31.7% and 68.3% were on sulfonylurea monotherapy and sulfonylurea+metformin, respectively. Mean±standard deviation age was 65.9±10.0 years; mean HbA1c level was 7.0%±1.0%; 77.8% of patients had hypertension (89.4% used antihypertensive medication); 60.5% had lipid disorders (72.5% used lipid-lower-ing medication); and 52.0% had one or more micro- or macrovascular diseases. Among patients with A1c measurement (n=717), 56.4% achieved therapeutic goals (HbA1c <7.0%); 42.4% (305/719) experienced hypoglycemia within 6 months of enrollment; and 38.8%, 12.9%, 12.7%, and 3.9% of patients experienced mild, moderate, severe, and very severe hypoglycemia symptoms, respec-tively. Several reported hypoglycemia frequency as 1–2 times over the last 6 months. The mean number of very severe hypoglyce-mia episodes was 3.5±5.5.Conclusion: Among type 2 diabetes mellitus patients treated with sulfonylurea-based regimens, glycemic levels were relatively well controlled but hypoglycemia remained a prevalent side effect.
Public Perceptions on Cancer Incidence and Survival: A Nation-wide Survey in Korea
김소연,신동욱,양형국,김소영,고영진,Be-Long Cho,이영성,이덕형,박기호,박종혁 대한암학회 2016 Cancer Research and Treatment Vol.48 No.2
Purpose The aim of this study was to compare the public perceptions of the incidence rates and survival rates for common cancers with the actual rates from epidemiologic data. Materials and Methods We conducted a survey of Korean adults without history of cancer (n=2,000). The survey consisted of questions about their perceptions regarding lifetime incidence rates and 5-year survival rates for total cancer, as well as those of eight site-specific cancers. To investigate associated factors, we included questions about cancer worry (Lerman’s Cancer Worry Scale) or cared for a family member or friend with cancer as a caregiver. Results Only 19% of Korean adults had an accurate perception of incidence rates compared with the epidemiologic data on total cancer. For specific cancers, most of the respondents overestimated the incidence rates and 10%-30% of men and 6%-18% of women had an accurate perception. A high score in “cancer worry” was associated with higher estimates of incidence rates in total and specific cancers. In cancers with high actual 5-year survival rates (e.g., breast and thyroid), the majority of respondents underestimated survival rates. However, about 50% of respondents overestimated survival rates in cancers with low actual survival rates (e.g., lung and liver). There was no factor consistently associated with perceived survival rates. Conclusion Widespread discrepancies were observed between perceived probability and actual epidemiological data. In order to reduce cancer worry and to increase health literacy, communication and patient education on appropriate risk is needed.